Statistical considerations for a trial of Ebola virus disease therapeutics
暂无分享,去创建一个
[1] P. O'Brien,et al. A multiple testing procedure for clinical trials. , 1979, Biometrics.
[2] KyungMann Kim. Group Sequential Methods with Applications to Clinical Trials , 2001 .
[3] M H Gail,et al. Applicability of sample size calculations based on a comparison of proportions for use with the logrank test. , 1985, Controlled clinical trials.
[4] P. Armitage,et al. Repeated Significance Tests on Accumulating Data , 1969 .
[5] P. Horby,et al. Trial design for evaluating novel treatments during an outbreak of an infectious disease , 2016, Clinical trials.
[6] J. Haybittle,et al. Repeated assessment of results in clinical trials of cancer treatment. , 1971, The British journal of radiology.
[7] S. Pocock. Group sequential methods in the design and analysis of clinical trials , 1977 .
[8] Kai Kupferschmidt,et al. Infectious Diseases. Ebola vaccine trials raise ethical issues. , 2014, Science.
[9] John Whitehead,et al. Group sequential trials revisited: Simple implementation using SAS , 2011, Statistical methods in medical research.
[10] J. Dushoff,et al. Ebola virus vaccine trials: the ethical mandate for a therapeutic safety net , 2014, BMJ : British Medical Journal.
[11] John Whitehead,et al. Evaluating Clinical Trial Designs for Investigational Treatments of Ebola Virus Disease , 2015, PLoS medicine.
[12] K. K. Lan,et al. Discrete sequential boundaries for clinical trials , 1983 .
[13] M. Fay,et al. Combining one‐sample confidence procedures for inference in the two‐sample case , 2015, Biometrics.
[14] T R Fleming,et al. Designs for group sequential tests. , 1984, Controlled clinical trials.
[15] G. Barnard,et al. A New Test for 2 × 2 Tables , 1945, Nature.
[16] Michael R. Chernick,et al. Statistical Monitoring of Clinical Trials: a Unified Approach , 2007, Technometrics.